MPhA News

Small Doses

August 30, 2019

News from MPhA

Mission Moment:

COP Faculty Participate in Nexus Summit

Several professors and students from the University of Minnesota College of Pharmacy recently attended and presented at the Nexus Summit 2019, a national conference hosted by the National Center for Interprofessional Practice and Education. Presenters included Jeannine Conway, PharmD, BCPS; Keri Hager, PharmD, BCACP; Anna Milone, PharmD, BCPS; Carolyn O’Donnell, PharmD student; Victoria Smith, PharmD student and Kristyn Williamson, PharmD. The conference was held in Minneapolis, Aug. 18-20.

Nexus Summit


At the Capitol this Week:

New MA Reimbursement Rate Now in Effect

From Minnesota Department of Human Services, July 19: Important changes were made to state law regarding the reimbursement rate for outpatient drugs covered by the fee-for-service (FFS) Medical Assistance (MA) program during the 2019 legislative session. See the Office of the Revisor Statutes SF 12 Bill Text Versions webpage for statutory references. DHS will reprocess claims for dates of service from July 1-18, 2019 on Aug. 29, 2019, and they will appear on pharmacies’ remittance advice on Sept. 17, 2019. Effective for claims with a date of service on or after July 1, 2019, the following changes will be incorporated into the MA reimbursement for outpatient drugs:

Drug reimbursement (ingredient cost, for example)

  • The reimbursement rate for drugs is the same for all pharmacies. The differential rate paid to rural independently owned pharmacies was eliminated.
  • The reimbursement rate for drugs is the lesser of the National Average Drug Acquisition Cost (NADAC) (brand or generic), the state maximum allowable cost or specialty maximum allowable cost, or the usual and customary charge submitted. If a drug does not have a NADAC, state maximum allowable cost and specialty maximum allowable cost, then the reimbursement rate is the lesser of the wholesale acquisition cost minus 2 percent or the usual and customary charge submitted.

Dispensing fee

  • The dispensing fee for “covered outpatient drugs”, as defined by
    federal law
    , will be increased to $10.48 from $3.65.
  • The dispensing fee for covered drugs that don’t meet the federal definition of a “covered outpatient drug” will remain $3.65. An example of a covered drug that doesn’t meet the definition of a “covered outpatient drug” is a covered over-the-counter (OTC) multivitamin.
  • The dispensing fee for all compounded intravenous solutions was changed to $10.48 per bag. All other dispensing fees for compounded intravenous products were eliminated.
  • The dispensing fee for covered OTC drugs will be prorated if a claim is for less than the manufacturer’s original package size.
  • The retrospective billing pharmacy OTC drug dispensing fee was eliminated.
  • The Long-term care blister card system dispensing fee was eliminated.

For full information, including details on 340B reimbursement, OTC drugs, MinnesotaCare tax, and additional changes, visit the Minnesota Health Care Programs website.

APMS

Minnesota News

MDH Warns of Severe Lung Injuries from Vaping

The Minnesota Department of Health (MDH) has identified nearly 20 Minnesota cases of severe lung illness confirmed or under investigation that are linked to vaping and e-cigarette use. Similar reports are coming in from other states recently; MDH is partnering with the Centers for Disease Control and Prevention (CDC) to determine a cause and steps that may be taken to prevent additional illness. One person has died as of Aug. 28 (that happened in Illinois).

In Minnesota, symptoms have resulted in hospital stays ranging from days to weeks, with some patients admitted to intensive care units. Use of marijuana-based products and in some cases nicotine-based products were reported by those interviewed. We are asking providers to report similar cases.

View the Full Report

Related: CDC website detailing the risks of e-cigarettes

National News

New EPA Rule on Drug Disposal Now in Effect

From American Pharmacists Association, August 20: The first deadline of a new rule from the Environmental Protection Agency (EPA) took effect on Aug. 21. Under the new rule, certain drugs may no longer be disposed of by flushing down the drain or toilet. The rule applies to pharmacies and drug stores, supermarkets and other grocery stores, hospitals, health clinics and nursing care facilities, among others.

The new rule loosens regulations about disposal of some OTC nicotine replacement therapies. Pharmacists should be aware of the contents of the new rule.

Read the APhA’s Article

Related: Read a summary of the final rule from the National Community Pharmacists Association.

Read the full text of the new rule at the Federal Register website.


Johnson & Johnson’s Brand Falters over its Role in Opioid Crisis

From Pharmacy Today, a publication of the American Pharmacists Association, August 28: On Aug. 26, a judge in Oklahoma ruled that Johnson & Johnson should be held responsible for decades of opioid addiction and must pay the state of Oklahoma $572 million (a fraction of what the state requested). The judge cited the company’s overly aggressive marketing tactics.

An article in The New York Times said some observers question how long Johnson & Johnson can weather a series of damaging setbacks to its brand, including whether its talcum powder led to ovarian cancer and high-profile cases over other potentially flawed products. The company said in a statement that the judge’s decision was flawed, and that it plans to appeal the case. Johnson & Johnson also defended its business as an opiate supplier, saying it followed state and federal regulations.


Purdue Pharmacy in Talks to Resolve Opioid Cases

From Pharmacy Today, a publication of the American Pharmacists Association, August 28: Purdue Pharma and its owners, the Sackler family, are reportedly in talks with state and local governments to resolve more than 2,000 opioid cases in a deal valued at between $10 and $12 billion. The latest proposal, which came out of settlement talks the week of Aug. 18 in Cleveland, would put Purdue in bankruptcy and have it emerge as a public benefit trust corporation, with proceeds going toward the governments bringing the lawsuits.


Prescription Drug Monitoring Programs: Friend or Folly in the Opioid Crisis?

From New England Journal of Medicine, August 22: The value of prescription drug monitoring programs (PDMPs) is being called into question. Data collected over the years suggest that PDMPs have helped check bad behaviors related to opioid prescribing and use, there have been complaints that the systems take treatment options away from clients, infringe on medical practice and potentially could compromise patient privacy. Writing in the New England Journal of Medicine, Rebecca L. Haffajee, JD, PhD, MPH, says the benefits of PDMPs easily outweigh the concerns.

Read the Full Article

MPhA Events

Register Now: MPhA Annual Learning Networking Event and MTM Symposium

October 3-4 • Minneapolis Marriott Northwest, Brooklyn Park

ALNE

We are pleased to present the agenda and speakers for this unique event as we bring together pharmacists, pharmacist students, pharmacy technicians, public health professionals and industry thought leaders for two days of cutting-edge programming and networking. Among the sessions and speakers:

  • Where’s the Interface with Public Health and Pharmacists’ Engagement in the Opioid and Substance Use Epidemic (Keynote Session), with Brent Thompson, PharmD, FirstLight Health System, and Laura Palombi, PharmD, MPH, MAT, University of Minnesota College of Pharmacy
  • Clinical Pearls sessions include Migraine Update with Natalie Roy, PharmD
  • A baker’s dozen of Roundtable sessions, including New Drug Update on Spravato, a Novel Antidepressant Nasal Spray, with Kyle Walburg, Pharmacy Associate, University of Minnesota College of Pharmacy and Sarah Massey, PharmD, Second-Year Pharmaceutical Care Resident, University of Minnesota College of Pharmacy

You won’t want to miss our Awards Reception on Thursday evening! Join us to congratulate this year’s recipients of the Harold R. Popp Award, Bowl of Hygeia, Distinguished Young Pharmacist Award, Excellence in Innovation Award, Pharmacy Technician Award and Pharmacy Advocate Award.

Register Now

Thanks to the following sponsors and exhibitors!

Lunch Sponsor: University of Minnesota College of Pharmacy
Coffee Sponsor: National Association of Chain Drug Stores
Silver Sponsors: Anda • Arkray USA, Inc. • AstraZeneca Diabetes • Lilly USA, LLC • Merck Vaccines • Novo Nordisk • Upsher Smith Laboratories
Exhibitors: Abbvie • Allergan • Amgen • Boehringer Ingelheim Pharmaceuticals • Gilead Sciences • IntegraDose Compounding • Janssen Neuroscience/Johnson & Johnson • McKesson • Merck & Co., Inc. • Minnesota Board of Pharmacy • Minnesota Department of Health • Minnesota Pharmacy Student Alliance • Pharmacists Mutual Companies • SpartanNash • Tabula Rasa Healthcare

Sponsorship opportunities are going quickly — don’t miss out!


APhA’s Pharmacy-based Immunization Delivery Certificate Training Program

Sunday, September 29 • 8 a.m.-5 p.m. • Ewald Conference Center, St. Paul • Registration Deadline: September 13

APhA’s Pharmacy-Based Immunization Delivery certificate training program is based on national educational standards for immunization training from the Centers for Disease Control and Prevention. This program is designed to educate pharmacists about the professional opportunities for vaccine advocacy and administration. This practice-based curriculum represents a fusion of science and clinical pharmacy. The program, which emphasizes a health care team approach, seeks to foster the implementation of interventions that will promote disease prevention and public health.

The purpose of this certificate training program is to prepare pharmacists with comprehensive knowledge, skills, and resources necessary to provide immunization services to patients across the life span.

This certificate training program has three components: online interactive self-study with assessment; the live seminar with online final assessment; and hands-on assessment of intramuscular and subcutaneous injection technique. A Certificate of Achievement will be awarded to participants who successfully complete all program components, including an evaluation.

Our faculty members are John Creasy, RPh; Laurie Deegan, RPh; and Melanie Schwartz, RPh; all are with Fairview Pharmacy Services.

Register Now!


APhA’s Delivering Medication Therapy Management Services Certificate Training Program

Friday, November 1 • 8 a.m.-5 p.m. • Ewald Conference Center, St. Paul

This program qualifies you to register as a provider with MN Medicaid and conduct and receive payment for Medication Therapy Management services. Certificate training program (3rd Edition) presents a systematic approach for developing, implementing, delivering, and sustaining MTM services. It includes an overview of the marketplace for delivering MTM services, guidance for implementing MTM services in pharmacy practice, a review of the essential skills and knowledge needed for performing MTM successfully, and an organized process for identifying medication-related problems. The purpose of this certificate training program is to prepare pharmacists to improve medication use through the delivery of MTM services in a variety of practice settings.

Our faculty members are Jordan Wolf, PharmD, Certified Geriatric Specialist, Consultant Pharmacist, Thrifty White Pharmacy, and Michelle A. Johnson, PharmD, BCACP, Pharmacist, Fairview Pharmacy Services. 

Register Now


Save the Dates: MPhA Events

October 8 • MPhA Town Hall • St. Cloud

October 10 • MPhA Town Hall • Duluth

October 15 • MPhA Town Hall • Alexandria

October 22 • MPhA Town Hall • Rochester

November 3 • MPhA Town Hall • Mora

November 7 • MPhA Town Hall • Grand Rapids

February 20, 2020 • Minnesota Pharmacy Legislative Day • Best Western Plus Capitol Ridge, St. Paul

In this Issue

News from MPhA

Mission Moment

At the Capitol this Week

Minnesota News

MDH Warns of Severe Lung Injuries from Vaping

National News

New EPA Rule on Drug Disposal Now in Effect

Johnson & Johnson’s Brand Falters over its Role in Opioid Crisis

Purdue Pharmacy in Talks to Resolve Opioid Cases

Prescription Drug Monitoring Programs: Friend or Folly in the Opioid Crisis?


Upcoming Events

APhA’s Pharmacy-based Immunization Delivery Certificate Training Program
September 29, 2019
8:00 a.m. - 5:00 p.m.

APhA’s Delivering Medication Therapy Management Services Certificate Training Program
November 1, 2019
8:00 a.m. - 5:00 p.m.

MPhA Annual Learning and Networking Event
October 3 - 4, 2019



Contact Us

Administrative Office
info@mpha.org

Executive Director
sarahd@mpha.org